Trial Design Solutions

  1. High-Content Flow Cytometry 6/17/2025

    Flow cytometry is a foundational tool in modern drug development, and its application in receptor occupancy assays has become essential for evaluating therapeutic engagement with disease targets.

  2. Signant SmartSignals® Advisory 5/15/2024

    Safeguard your protocol and endpoint data integrity with our expert support team, increasing your confidence, reducing workloads, and minimizing risks in data quality across all trial phases.

  3. User Acceptance Testing (UAT): Keeping Trials On Track 12/5/2025

    Validate endpoint performance and security before deployment with structured UAT that reduces risk, ensures compliance, and enhances user experience through real-world testing.

  4. New Is Risky. Start With A Free Feasibility Report. 7/23/2024

    Get a free preliminary evaluation of your protocol design from a leading CRO in Eastern Europe.

  5. Why Australia Is The Best Place In The World For Early Phase Studies 8/8/2024

    The Australian Advantage is about saving time and minimizing costs while generating internationally accepted data in preparation for the next Phase.

  6. Designed Around Your Needs: Let's Accelerate Enrollment Together 7/15/2025

    CSSi offers unmatched depth and breadth in therapeutic expertise, providing full-spectrum, in-house capabilities, positing the organization as a true end-to-end partner in clinical trials.

  7. Accelerate Clinical Trial Cycle Times With Citeline Study Feasibility 6/29/2021

    Citeline Study Feasibility is a platform that combines subject-matter expertise and machine learning to develop predictive insights for feasibility planning. Clinical trial sponsors can use these insights to identify key data drivers and model their impact, build and simulate feasibility scenarios, accelerate timelines, and make better decisions than with statistical methods alone.

  8. Ophthalmic Clinical Research Services 1/26/2023

    With over 40 clinical trials conducted in the area of ophthalmology, Altasciences combines depth of knowledge and expert capabilities to offer you a full range of early ophthalmic clinical development.

  9. Making The Impossible Possible In Oncology And Hematology Clinical Development 9/20/2023

    When the complexities of designing and executing cancer trials in a highly competitive market can mean delays in delivering urgently needed treatments to patients, it pays to have a trusted partner by your side.

  10. Integrating Lyft Pass To Increase Flexibility For Trial Participants 12/5/2025

    Whether used for routine appointments or trial participation, Lyft Pass ensures that patients have timely access to transportation, supporting adherence to schedules and improving overall engagement.